Navigation Links
InVitria Cell Culture Product Line to Headline PEACe
Date:9/16/2009

InVitria to showcase its high performance cell culture media supplements at 9th Annual Conference on Protein Expression in Animal Cells (PEACe) in Jackson Hole, WY, Sept. 19-23.

Fort Collins, CO (PRWEB) September 16, 2009 -- InVitria will showcase its line of high performance, well defined and regulatory friendly cell culture media supplements at the 9th Annual PEACe conference to be held in Jackson Hole, WY, Sept. 19-23.

A major part of the PEACe conference is the industrial workshop session, where InVitria's Director of Cell Culture Optimization, Dr. Steve Pettit, will present two of the company's newest cell culture products for CHO Cell Culture and Hybridoma Cell Culture: Zap-CHO and Optiferrin.

About Zap-CHO
"Zap-CHO is a CHO cell culture media supplement that delivers superior growth, faster cell line development and expansion and optimal productivity," said Dr. Pettit. "Additionally, it replaces fetal bovine serum (FBS) in CHO cell culture with a well defined and completely animal component free supplement. This enables biomanufacturing customers to eliminate the risk of virus and other infectious contaminants emanating from animal-derived media components like fetal bovine serum," he said.

About Optiferrin
Optiferrin is an animal-free recombinant human transferrin that efficiently delivers iron to cells including stem cells, primary cells, CHO and hybridoma cells. "Optiferrin is a preferred alternative to iron chelators or animal-derived transferrin in cell culture," said Dr. Pettit. "Optiferrin transfers iron to cells so that they receive exactly the amount of iron it needs for growth," he continued.

InVitria's sponsorship of PEACe kick-offs the fall industry events tour. "InVitria is extremely excited to be a part of PEACe," said Randy Semadeni, InVitria's Vice President of Business Development. "We see PEACe as an ideal event to interact with dynamic leaders from the mammalian cell culture industry while also sharing the powerful benefits of InVitria's line of high performance cell culture media supplements."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's product line, contact us at 1-800-916-8311.

###

Read the full story at http://www.prweb.com/releases/Zap-CHO/CHO-cell-culture-media/prweb2887874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria Sponsors ESACT 2009 in Dublin, Ireland
2. InVitria to Present at BIO 2009 International Convention in Atlanta
3. InVitria Reveals Technology to Optimize Hybridoma Production Performance
4. InVitria Headlines Sponsorship of WilBio's Waterside Conference
5. InVitria Announces Launch of Recombinant Albumin for Diagnostics
6. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
7. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
8. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
9. InVitria to Showcase its Innovative Cell Culture Components at American Society of Cell Biology Annual Meeting
10. InVitria to Present at WilBio's International Cell Engineering Meeting
11. New Survey Identifies Specialized Training and Respect for Culture as Key Factors in Healthcare Security Personnel Selection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... , ... The Waismann Method® is providing a faster, safer, and ... victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... the shame, stigma, and harmful labeling believed to prevent many of these ...
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important webinar— ... 23, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , If you want to find out what really happened in the seniors ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... the quarter and full fiscal year ended December 31, 2016. ... ... Company,s audited financial statements and management discussion and analysis for ... been filed on SEDAR and are available at www.sedar.com ...
(Date:2/22/2017)... Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... its Fourth Quarter 2016 investor conference call and webcast at ... The call will cover an update on Merrimack,s recent ... full year 2016 financial results. A press release detailing the ... the morning of Wednesday, March 1. Investors and the general ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... non-small cell lung cancer partnering deals and agreements entered ... the full report: http://www.reportlinker.com/p03605668-summary/view-report.html Description The ... since 2010 report provides understanding and access to partnering ... healthcare companies. - Trends in partnering deals ...
Breaking Medicine Technology: